The Edwards Lifesciences Evoque transcatheter tricuspid valve replacement system demonstrated sustained favorable patient outcomes at six months in the TRISCEND study.
November 08, 2021
Six-Month Outcomes Positive for Transfemoral Tricuspid Valve in Tricuspid Regurgitation Patients
November 8, 2021 — Results from a clinical trial of the Edwards Lifesciences Evoque transcatheter tricuspid valve…
Read More
The ControlRad device collimates the area of interest where the physicians are working, and reduces the dose significantly to peripheral areas in the image.
November 05, 2021
Beaumont Uses New Cardiac Cath Lab Technology to Reduce Radiation Exposure 
November 5, 2021 – An FDA-approved device used during cardiac cath lab procedures cut radiation exposure for…
Read More
A Johns Hopkins Medicine study of nearly 4,500 patients hospitalized with COVID-19 suggests that statins — medications widely used to control cholesterol — are not helpful in reducing COVID-related mortality or the severity of the illness. Graphic created by M.E. Newman, Johns Hopkins Medicine
November 05, 2021
Statins Likely Not Helpful In Reducing COVID Mortality or Severity
November 5, 2021 — In the worldwide effort to battle COVID-19 (SARS-CoV-2), researchers have often turned to…
Read More
Katherine Fornell, age 5, from suburban Chicago, receives her first dose of the COVID-19 vaccine during the first week it became available in the U.S. The FDA authorized the emergency use of the Pfizer-BioNTech COVID-19 vaccine Oct. 29 for the prevention of COVID-19 in children 5 to 11 years of age. This was based on a safety review of more than 3,000 patients receiving the vaccine ages 5-11.
November 05, 2021
FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine for Children Ages 5-11
November 5, 2021 — The U.S. Food and Drug Administration (FDA) authorized the emergency use of the Pfizer-BioNTech…
Read More
American Society of Nuclear Cardiology (ASNC) President Randy Thompson, M.D., getting his COVID-19 vaccine when the vaccines first became available last December. Nearly a year later, some healthcare workers are still holding out and refuse to get the vaccine, which prompted CMS (Medicare) to now require COVID vaccinations for all healthcare workers at facilities that accept Medicare and Medicaid patients.
By Dave Fornell, DAIC Editor
November 04, 2021
CMS Now Requires COVID-19 Vaccinations for Healthcare Workers by January 4
November 4, 2021 — The Centers for Medicare and Medicaid Services (CMS) today issued an emergency regulation now…
Read More
Figures from an initial study on the Cardionomic CPNS technology in a poster presentation at the Heart Rhythm Society (HRS) 2021 meeting.[1]  Starting at top left, an angiographic view of the atrial transseptal access for a left ventricular septal ablation. Procedural intra-cardiac echo (ICE) showing ablation catheter positioning. A 3D electro-anatomic map of the LV septum. The final graphs show baseline and post-procedure LVOT pressure readings demonstrating a decreased gradient.
November 02, 2021
First U.S. Patient Enrolled in Cardiac Pulmonary Nerve Stimulation Pilot Study to Treat Heart Failure
November 2, 2021 — Cardionomic Inc. announce initial U.S. enrollment in its global Cardiac Pulmonary Nerve Stimulation…
Read More
Cardiosave Hybrid Intra-Aortic Balloon Pump (IABP) left, and the Cardiosave Rescue Intra-Aortic Balloon Pump. Both systems have a recall because of reports that the battery can fail.
November 02, 2021
Cardiosave Intra-Aortic Balloon Pumps Recalled Due to Battery Failure
 November 2, 2021 — Datascope/Getinge/Maquet is recalling its Cardiosave Hybrid/Rescue Intra-Aortic Balloon Pumps (IABP…
Read More
T1-Based Criteria for Myocarditis on Cardiac MRI in Patients With Recent COVID-19 mRNA Vaccination: Early gadolinium enhancement (EGE) compared with precontrast SSFP sequence (not shown) is observed on early postcontrast short-axis SSFP images in (A) 16-year-old male, (B) 17-year-old male, (C) 16-year-old male, and (D) 19-year-old male, and on early postcontrast short-axis perfusion image in (E) 17-year-old male (arrow, A-E). Late gadolinium enhancement (LGE) is also present (arrows) in all 5 patients (F, G
November 01, 2021
Cardiac MRI of Myocarditis After COVID-19 Vaccination in Adolescents
November 1, 2021 — According to ARRS’ American Journal of Roentgenology (AJR), radiologists need to be cognizant of the…
Read More
The FDA cleared the world's first photon-counting computed tomography (CT) scanner, the Siemens Naeotom Alpha, in late September. This new technology will likely change the future direction of CT. Biosense Webster also announced the first cases using its Heliostar radiofrequency balloon ablation catheter were completed in September. Both were among the top stories in October.
By Dave Fornell, DAIC Editor
November 01, 2021
Most Popular Cardiology Technology Content in October 2021
November 1, 2021 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC)…
Read More
The Vagus Breathe ECG app for the Apple Watch is the first test to measure the exact breathing flow with an electrocardiogram (ECG) recording. It uses a 30-second breathing test for wearable device. It is being used to monitor long-COVID patients.
November 01, 2021
Apple Watch Adds New Breathing Test Based on ECG Analysis
November 1, 2021 — Health AI company Vagus.co, based in Cambridge, U.K., has launched a 30-second breathing test for…
Read More
Cardiac CT Given Strong Recommendation as Front-line Imaging of Chest Pain, but the American Society of Nuclear Cardiology (ASNC) did not support the guidelines.
By Dave Fornell, DAIC Editor
October 29, 2021
First International Chest Pain Diagnosis Guidelines Released
October 29, 2021 — A new guideline for the evaluation and diagnosis of chest pain was released this week that provides…
Read More
Implicity provides a remote cardiac monitoring and research platform used by Independent Diagnostic Testing Facilities and medical centers to deliver high-quality care for patients with connected cardiac devices. On this platform, Implicity aggregates, normalizes and standardizes data from any implantable cardiac device across all manufacturers.
By Arnaud Rosier, M.D.
October 28, 2021
Addressing Physician Concerns About Missing CIED Patient Data
With 1.2 to 1.4 million new electrophysiology (EP) devices being prescribed to patients around the world each year,…
Read More
BioCardia's CardiAMP cell therapy uses a patient’s own (autologous) bone marrow cells delivered to the heart in a minimally invasive, catheter-based procedure to potentially stimulate the body’s natural healing response. The therapy incorporates a pre-procedural screening assay to identify those patients who are likely responders to the therapy, a first for a cardiac cell therapy. 
October 28, 2021
BioCardia Announces First Patient Treated in CardiAMP Cell Therapy Trial for Chronic Myocardial Ischemia
October 28, 2021 – The first patient has been treated in a new trial using stem cell therapy to treat chronic…
Read More
The CathVision's novel EP recording technology and amplifier ECGenius used artificial intelligence (AI) confirms if pulmonary vein isolation (PVI) is complete to reduce need for repeat EP ablations procedures.
October 28, 2021
CathVision Announces First Patient Enrollments in PVISION Multicenter Clinical Study
October 28, 2021 — CathVision, a medical technology company developing electrophysiology (EP) solutions in EP recording…
Read More
Cardiovascular Ultrasound Analytics Aids Re-accreditation Process 
October 27, 2021
The Benefits of Data Analytics in Clinical Reporting
Accurate reporting is essential to producing the reliable analytics needed to meet lab accreditation standards. This is…
Read More
October 27, 2021
FDA Revises Impulse Dynamics Optimizer Smart Device Labeling Opening it to More Patients
October 27, 2021 — Impulse Dynamics announced the U.S. Food and Drug Administration approved a modification of labeling…
Read More
October 27, 2021
Leadless CRT Can Deliver Left Bundle Branch Area Pacing for Cardiac Resynchronization
October 27, 2021 ​​— EBR Systems Inc., developer of the world’s first wireless cardiac pacing system for heart failure…
Read More
QuickClot already has an FDA-cleared product for use for vascular access hemostasis management in cath lab procedures. The hemostatic technology consists of a non-woven material impregnated with kaolin, an inorganic mineral. When kaolin contacts blood it activates Factor XII, which accelerates the body’s natural clotting cascade.
October 27, 2021
Teleflex Completes Enrollment in IDE Study of QuickClot in Cardiac Surgery
October 27, 2021 — Teleflex Inc. announced the completion of patient enrollment in a clinical study evaluating the…
Read More
By Dave Fornell, DAIC Editor
October 21, 2021
Advances in Intravascular Ultrasound Technologies
Intravascular ultrasound (IVUS) is the workhorse intravascular imaging modality in cardiac cath labs. It is used to…
Read More
HeartFlow, Inc., a leader in revolutionizing precision heart care, announced the commencement of the REVEALPLAQUE (A pRospEctiVe, multicEnter study to AnaLyze PLAQUE using CCTA) trial to evaluate HeartFlow’s non-invasive plaque technology, an automated, deep learning-based method for identifying, characterizing and segmenting plaque in the coronary arteries
October 20, 2021
HeartFlow Announces Enrollment of First Two Patients in REVEALPLAQUE Trial
October 20, 2021 — HeartFlow Inc. announced the commencement of the REVEALPLAQUE (A pRospEctiVe, multicEnter study to …
Read More
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now